Capital Fund Management (CFM)’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.97M Sell
72,700
-62,700
-46% -$8.93M 0.04% 657
2025
Q4
$22.5M Sell
135,400
-13,800
-9% -$2.31M 0.06% 445
2025
Q3
$29.2M Buy
149,200
+18,100
+14% +$2.98M 0.08% 358
2025
Q2
$11.9M Buy
131,100
+82,200
+168% +$6.49M 0.03% 662
2025
Q1
$2.92M Buy
48,900
+20,100
+70% +$1.86M 0.01% 1256
2024
Q4
$3.81M Sell
28,800
-32,400
-53% -$3.04M 0.01% 1209
2024
Q3
$3.21M Buy
+61,200
New +$2.87M 0.01% 1223

Other funds holding ALAB

Capital Fund Management (CFM)'s ALAB Position: Q2 2025 in Review

Capital Fund Management (CFM) sold out of Astera Labs (ALAB) in Q2 2025, closing a stake of 303,243 shares — an estimated $24M sold.

Capital Fund Management (CFM) first reported a position in ALAB in Q4 2024 and held it in 2 quarters. The position peaked at $24.8M in Q4 2024. 513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

  • Capital Fund Management (CFM) reported no remaining Astera Labs position as of Q2 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 303,243 Astera Labs shares in Q2 2025, an estimated $24M.
  • Capital Fund Management (CFM) first reported a position in Astera Labs in Q4 2024 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s Astera Labs position peaked at $24.8M in Q4 2024.
  • 513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2025, filed 13 Aug 2025.